Human prion disease surveillance in Spain, 1993-2018: an overview

References

• Prusiner SB. The prion diseases. Brain Pathol. 1998;8(3):499–513. PMID: 9669700.
   PubMed Web of Science ®Google Scholar
• The UK National Archives. The BSE inquiry: the report. National Archives UK BSE inquiry. 25 May 2006. Available from: https://webarchive.nationalarchives.gov.uk/20060525120000/http://www.bseinquiry.gov.uk/report/volume8/toc.htm. Accessed on 2021 Feb 16.
   Google Scholar
• Alperovitch A, Brown P, Weber T, et al. Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet. 1994;343(8902):918. PMID: 7908378.
   PubMed Web of Science ®Google Scholar
• Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921–925. PMID: 8598754.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. European Creutzfeldt-Jakob Disease Surveillance Network (EuroCJD). European Centre for Disease Prevention and Control, 2021. Available from https://www.ecdc.europa.eu/en/about-us/who-we-work/disease-and-laboratory-networks/european-creutzfeldt-jakob-disease Accessed on 2021 Feb 16.
   Google Scholar
• Westermark GT, Westermark P. Prion-like aggregates: infectious agents in human disease. Trends Mol Med. 2010;16(11):501–507. PMID: 20870462.
   PubMed Web of Science ®Google Scholar
• García-Armesto S, Abadía-Taira MB, Durán A, et al. Spain: health system review. Health Syst Transit. 2010;12(4):1–xx. PMID: 21224176.
   PubMedGoogle Scholar
• Martínez-Lage JF, Poza M, Sola J, et al. Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neurol Neurosurg Psychiatry. 1994;57(9):1091–1094. PMID: 8089676.
   PubMed Web of Science ®Google Scholar
• Spain’s Ministry of Health and Consumption. Orden de 21 de octubre de 1996 por la que se amplía la de 21 de julio de 1994 por la que se regulan los ficheros con datos de carácter personal gestionados por el Ministerio de Sanidad y Consumo (2016). Available from https://www.boe.es/eli/es/o/1996/10/21/(1). Accessed on 2021 Feb 16.
   Google Scholar
• Saiz A, Nos C, Yagüe J, et al. The impact of the introduction of the 14-3-3 protein assay in the surveillance of sporadic Creutzfeldt-Jakob disease in Catalonia. J Neurol. 2001;248(7):592–594. PMID: 11518001.
   PubMed Web of Science ®Google Scholar
• Kovács GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166–174. PMID: 16187142.
   PubMed Web of Science ®Google Scholar
• De Pedro-Cuesta J, Glatzel M, Almazã¡n J, et al. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health. 2006;6(1):278. PMID: 17096829.
   PubMedGoogle Scholar
• Alcalde-Cabero E, Almazan-Isla J, Brandel JP, et al. Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. Euro Surveill. 2012;17(15). https://doi.org/10.2807/ese.17.15.20144-en PMID: 22516047.
   Google Scholar
• Van Duijn CM, Delasnerie-Laupretre N, Masullo C, et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) collaborative study group of Creutzfeldt-Jakob disease (CJD). Lancet. 1998;351(9109):1081–1085. PMID: 9660576.
   PubMedGoogle Scholar
• Spain’s Ministry of Health and Consumption. Guía ECJ. 2003. Available from: https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/docs/GuiaECJ.pdf. Accessed on 2021 Feb 16.
   Google Scholar
• Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55(6):811–815. PMID: 10994001.
   PubMed Web of Science ®Google Scholar
• Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt10):2659–2668. PMID: 19773352.
   PubMedGoogle Scholar
• De Pedro-cuesta J, Rábano A, Martínez-Martín P, et al. Comparative incidence of conformational, neurodegenerative disorders. PLoS One. 2015;10(9):e0137342. PMID: 26335347.
   PubMed Web of Science ®Google Scholar
• Riverol M, Palma JA, Alañá M, et al. Variant Creutzfeldt-Jakob disease occurring in mother and son. J Neurol Neurosurg Psychiatry. 2012;83(2):235–236. PMID: 21257982.
   PubMed Web of Science ®Google Scholar
• Lenglet A, Hernandez Pezzi G. Comparison of the European Union disease surveillance networks’ websites. Euro Surveill. 2006;11(5):119–122. PMID: 16757848.
   PubMedGoogle Scholar
• Pocchiari M, Puopolo M, Croes EA, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;127(Pt10):2348–2359. PMID: 15361416.
   PubMedGoogle Scholar
• Nagoshi K, Sadakane A, Nakamura Y, et al. Duration of prion disease is longer in Japan than in other countries. J Epidemiol. 2011;21(4):255–262. PMID: 21628843.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu CC, Fan LY, et al. Incidence of and mortality due to human prion diseases in Taiwan: a prospective 20-year nationwide surveillance study from 1998 to 2017. Clin Epidemiol. 2020;12:1073–1081. PMID: 33116901.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Martínez AB, Barreau C, Coupry I, et al. Ancestral origins of the prion protein gene D178N mutation in the Basque Country. Hum Genet. 2005;117(1):61–69. PMID: 15806397.
   PubMed Web of Science ®Google Scholar
• Diack AB, Boyle A, Ritchie D, et al. Similarities of variant Creutzfeldt-Jakob disease strain in mother and son in Spain to UK reference case. Emerg Infect Dis. 2017;23(9):1593–1596. PMID: 28820380.
   PubMed Web of Science ®Google Scholar
• Sanchez-Juan P, Cousens SN, Will RG, et al. Source of variant Creutzfeldt-Jakob disease outside United Kingdom. Emerg Infect Dis. 2007;13(8):1166–1169. PMID: 17953086.
   PubMed Web of Science ®Google Scholar
• Geschwind MD, Shu H, Haman A, et al. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97–108. PMID: 18668637.
   PubMed Web of Science ®Google Scholar
• De Pedro-Cuesta J, Mahillo-Fernández I, Rábano A, et al. Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry. 2011;82(2):204–212. PMID: 20547628.
   PubMed Web of Science ®Google Scholar
• ECDC interim risk assessment. Questions on variant Creutzfeldt–Jakob disease and blood transfusion. March 2010, updated Jul 2011. Stockholm: ECDC, 2011. Available from https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/110921_TER_Risk%20assessment_vCJD.pdf. Accessed on 2021 Feb 16.
   Google Scholar
• European Centre for Disease Control and Prevention. Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in medical settings in EU Member States and Norway. Stockholm: ECDC, 2011. Available from https://www.ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/1106_TER_Review_of_guidelines_for_prevention_of%20CJD.pdf. Accessed on 2021 Feb 16.
   Google Scholar
• Heinemann U, Krasnianski A, Meer B, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt5):1350–1359. PMID: 17472986.
   PubMedGoogle Scholar
• Budka H, Will RG. The end of the BSE saga: do we still need surveillance for human prion diseases? Swiss Med Wkly. 2015;145:w14212. PMID: 26715203.
   PubMed Web of Science ®Google Scholar
• De Pedro-Cuesta J, Martínez-Martín P, Rábano A, et al. Etiologic framework for the study of neurodegenerative disorders as well as vascular and metabolic comorbidities on the grounds of shared epidemiologic and biologic features. Front Aging Neurosci. 2016;8:138. PMID: 27378910.
   PubMed Web of Science ®Google Scholar